PLEASANTON, Calif., April 18, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
PLEASANTON, Calif., April 15, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended ...
Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.
10x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.19. Operator: Thank you for standing by. My name is Carly, and I will be your conference operator today.
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
Image source: The Motley Fool. 10x Genomics (NASDAQ:TXG) reported quarterly revenue of $166,000,000, reflecting low single-digit growth and surpassing guidance, while full-year revenue excluding ...
With a trio of partnership announcements this month, 10x Genomics has signaled it is looking beyond its traditional focus on research tools for academic, government, and industry customers, by ...
PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a ...
Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results